Sangamo Therapeutics Inc (NASDAQ:SGMO)

8.19
Delayed Data
As of Dec 06
 +0.11 / +1.36%
Today’s Change
7.81
Today|||52-Week Range
19.43
-47.52%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Macrae Alexander D
President & Chief Executive Officer
Sale2/25/202135,311$11.19$395.1K-26.63%
Biogen Inc
Sale11/26/202128,884$8.60$248.4K-2.84%
Mcclung Mark D
EVP & Chief Business Officer
Sale6/25/202111,525$12.02$138.5K-31.70%
Ramasastry Sona Saira /glenmark/
Director
Sale12/17/202010,000$13.27$132.7K-38.73%
Ramelmeier R Andrew /sangamo/
EVP-Technical Operations
Sale2/25/20217,779$11.19$87.0K-26.63%
Loeb Gary H
General Counsel, Secretary & EVP
Sale2/25/20215,762$11.19$64.5K-26.63%
Ramelmeier R Andrew /sangamo/
EVP-Technical Operations
Sale12/24/20203,331$18.13$60.4K-53.90%
Ramasastry Sona Saira /glenmark/
Director
Buy12/17/202010,000$5.99$59.9K-38.73%
Macrae Alexander D
President & Chief Executive Officer
Sale1/24/20213,977$14.95$59.5K-45.45%
Ramelmeier R Andrew /sangamo/
EVP-Technical Operations
Sale12/31/20202,464$16.74$41.2K-47.39%
Page of 4